Arteriogenic therapy based on simultaneous delivery of VEGF-A and FGF4 genes improves the recovery from acute limb ischemia

Vascular Cell

Volumn 5, Issue 1, 2013, Pages

  Jazwa, Agnieszka ^a   Tomczyk, Mateusz ^a   Taha, Hevidar M ^a   Hytonen, Elisa ^b   Stoszko, Mateusz ^a   Zentilin, Lorena ^c   Giacca, Mauro ^c   Yla Herttuala, Seppo ^b   Emanueli, Costanza ^d   Jozkowicz, Alicja ^a   Dulak, Jozef ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c INTERNATIONAL CENTRE FOR GENETIC ENGINEERING AND BIOTECHNOLOGY   (Italy)

^d UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

AAV; Angiogenesis; Arteriogenesis; FGF4; VEGF A

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; FIBROBLAST GROWTH FACTOR 4; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CAPILLARY WALL; CONTROLLED STUDY; DRUG POTENTIATION; FEMORAL ARTERY; HUMAN; HUMAN CELL; INCIDENCE; LIGATION; LIMB BLOOD FLOW; LIMB ISCHEMIA; MALE; MOUSE; MUSCLE PERFUSION; NONHUMAN; PRIORITY JOURNAL;

MURINAE; MUS;

EID: 84879483002     PISSN: None     EISSN: 2045824X     Source Type: Journal    
DOI: 10.1186/2045-824X-5-13     Document Type: Article

References (41)

1. Gene therapy for ischemic cardiovascular diseases: some lessons learned from the first clinical trials. Yla-Herttuala S, Markkanen JE, Rissanen TT, Trends Cardiovasc Med 2004 14 295 300 10.1016/j.tcm.2004.09.001 15596105 (Pubitemid 41110607)
2. VEGF gene therapy: therapeutic angiogenesis in the clinic and beyond. Giacca M, Zacchigna S, Gene Ther 2012 19 622 629 10.1038/gt.2012.17 22378343
3. The well-tempered vessel. Blau HM, Banfi A, Nat Med 2001 7 532 534 10.1038/87850 11329048 (Pubitemid 32448310)
4. Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy. Dor Y, Djonov V, Abramovitch R, Itin A, Fishman GI, Carmeliet P, Goelman G, Keshet E, EMBO J 2002 21 1939 1947 10.1093/emboj/21.8.1939 11953313 (Pubitemid 34437191)
5. VEGF gene delivery to myocardium: deleterious effects of unregulated expression. Lee RJ, Springer ML, Blanco-Bose WE, Shaw R, Ursell PC, Blau HM, Circulation 2000 102 898 901 10.1161/01.CIR.102.8.898 10952959
6. Evaluation of the effects of intramyocardial injection of DNA expressing vascular endothelial growth factor (VEGF) in a myocardial infarction model in the rat-angiogenesis and angioma formation. Schwarz ER, Speakman MT, Patterson M, Hale SS, Isner JM, Kedes LH, Kloner RA, J Am Coll Cardiol 2000 35 1323 1330 10.1016/S0735-1097(00)00522-2 10758976 (Pubitemid 30206908)
7. Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2. Masaki I, Yonemitsu Y, Yamashita A, Sata S, Tanii M, Komori K, Nakagawa K, Hou X, Nagai Y, Hasegawa M, et al. Circ Res 2002 90 966 973 10.1161/01.RES.0000019540.41697.60 12016262 (Pubitemid 34633862)
8. Assessment of risks associated with cardiovascular gene therapy in human subjects. Isner JM, Vale PR, Symes JF, Losordo DW, Circ Res 2001 89 389 400 10.1161/hh1701.096259 11532899 (Pubitemid 34132654)
9. Sustained improvement in perfusion and flow reserve after temporally separated delivery of vascular endothelial growth factor and angiopoietin-1 plasmid deoxyribonucleic Acid. Smith AH, Kuliszewski MA, Liao C, Rudenko D, Stewart DJ, Leong-Poi H, J Am Coll Cardiol 2012 59 1320 1328 10.1016/j.jacc.2011.12.025 22464261
10. Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors. Arsic N, Zentilin L, Zacchigna S, Santoro D, Stanta G, Salvi A, Sinagra G, Giacca M, Mol Ther 2003 7 450 459 10.1016/S1525-0016(03)00034-0 12727107 (Pubitemid 36553413)
11. Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization. Chae JK, Kim I, Lim ST, Chung MJ, Kim WH, Kim HG, Ko JK, Koh GY, Arterioscler Thromb Vasc Biol 2000 20 2573 2578 10.1161/01.ATV.20.12.2573 11116055
12. Polymeric system for dual growth factor delivery. Richardson TP, Peters MC, Ennett AB, Mooney DJ, Nat Biotechnol 2001 19 1029 1034 10.1038/nbt1101-1029 11689847 (Pubitemid 33041886)
13. Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion role of vessel maturation. Kupatt C, Hinkel R, Pfosser A, El-Aouni C, Wuchrer A, Fritz A, Globisch F, Thormann M, Horstkotte J, Lebherz C, et al. J Am Coll Cardiol 2010 56 414 422 10.1016/j.jacc.2010.03.050 20650363
14. Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogenic vessels. Korpisalo P, Karvinen H, Rissanen TT, Kilpijoki J, Marjomaki V, Baluk P, McDonald DM, Cao Y, Eriksson U, Alitalo K, et al. Circ Res 2008 103 1092 1099 10.1161/CIRCRESAHA.108.182287 18832750
15. Requirement of FGF-4 for postimplantation mouse development. Feldman B, Poueymirou W, Papaioannou VE, DeChiara TM, Goldfarb M, Science 1995 267 246 249 10.1126/science.7809630 7809630
16. FGF-4 replaces the apical ectodermal ridge and directs outgrowth and patterning of the limb. Niswander L, Tickle C, Vogel A, Booth I, Martin GR, Cell 1993 75 579 587 10.1016/0092-8674(93)90391-3 8221896 (Pubitemid 23335082)
17. BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers. Adnane J, Gaudray P, Dionne CA, Crumley G, Jaye M, Schlessinger J, Jeanteur P, Birnbaum D, Theillet C, Oncogene 1991 6 659 663 1851551 (Pubitemid 21924133)
18. Detection of spatial localization of Hst-1/Fgf-4 gene expression in brain and testis from adult mice. Yamamoto H, Ochiya T, Takahama Y, Ishii Y, Osumi N, Sakamoto H, Terada M, Oncogene 2000 19 3805 3810 10.1038/sj.onc.1203752 10949936 (Pubitemid 30621187)
19. Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model. Rissanen TT, Markkanen JE, Arve K, Rutanen J, Kettunen MI, Vajanto I, Jauhiainen S, Cashion L, Gruchala M, Narvanen O, et al. FASEB J 2003 17 100 102 12475908
20. Increased regional function and perfusion after intracoronary delivery of adenovirus encoding fibroblast growth factor 4: report of preclinical data. Gao MH, Lai NC, McKirnan MD, Roth DA, Rubanyi GM, Dalton N, Roth DM, Hammond HK, Hum Gene Ther 2004 15 574 587 10.1089/104303404323142024 15212716 (Pubitemid 41071205)
21. Combined vascular endothelial growth factor-A and fibroblast growth factor 4 gene transfer improves wound healing in diabetic mice. Jazwa A, Kucharzewska P, Leja J, Zagorska A, Sierpniowska A, Stepniewski J, Kozakowska M, Taha H, Ochiya T, Derlacz R, et al. Genet Vaccines Ther 2010 8 6 10.1186/1479-0556-8-6 20804557
22. Vascular endothelial growth factor is efficiently synthesized in spite of low transfection efficiency of pSG5VEGF plasmids in vascular smooth muscle cells. Dulak J, Jozkowicz A, Ratajska A, Szuba A, Cooke JP, Dembinska-Kiec A, Vasc Med 2000 5 33 40 10737154 (Pubitemid 30143360)
23. Konstrukcja plazmidowych wektorów bicistronowych i zastosowanie do transfekcji in vitro. Kucharzewska P, Zagorska A, Leja J, Jazwa A, Gozdecka M, Jozkowicz A, Dulak J, Biotechnologia 2007 3 66 81 (Pubitemid 47442094)
24. Adeno-associated virus-mediated gene transfer of a secreted decoy human macrophage scavenger receptor reduces atherosclerotic lesion formation in LDL receptor knockout mice. Jalkanen J, Leppanen P, Pajusola K, Narvanen O, Mahonen A, Vahakangas E, Greaves DR, Bueler H, Yla-Herttuala S, Mol Ther 2003 8 903 910 10.1016/j.ymthe.2003.09.012 14664792 (Pubitemid 38081221)
25. Angiopoietin-1 gene transfer improves impaired wound healing in genetically diabetic mice without increasing VEGF expression. Bitto A, Minutoli L, Galeano MR, Altavilla D, Polito F, Fiumara T, Calo M, Lo Cascio P, Zentilin L, Giacca M, et al. Clin Sci (Lond) 2008 114 707 718 10.1042/CS20070250 (Pubitemid 351799330)
26. Local delivery of human tissue kallikrein gene accelerates spontaneous angiogenesis in mouse model of hindlimb ischemia. Emanueli C, Minasi A, Zacheo A, Chao J, Chao L, Salis MB, Straino S, Tozzi MG, Smith R, Gaspa L, et al. Circulation 2001 103 125 132 10.1161/01.CIR.103.1.125 11136697 (Pubitemid 32050447)
27. Pre-emptive hypoxia-regulated HO-1 gene therapy improves post-ischaemic limb perfusion and tissue regeneration in mice. Jazwa A, Stepniewski J, Zamykal M, Jagodzinska J, Meloni M, Emanueli C, Jozkowicz A, Dulak J, Cardiovasc Res 2013 97 115 124 10.1093/cvr/cvs284 23087099
28. Adenovirus-mediated human tissue kallikrein gene delivery induces angiogenesis in normoperfused skeletal muscle. Emanueli C, Zacheo A, Minasi A, Chao J, Chao L, Salis MB, Stacca T, Straino S, Capogrossi MC, Madeddu P, Arterioscler Thromb Vasc Biol 2000 20 2379 2385 10.1161/01.ATV.20.11.2379 11073841
29. New aspects in vascular gene therapy. Karvinen H, Yla-Herttuala S, Curr Opin Pharmacol 2010 10 208 211 10.1016/j.coph.2010.01.004 20163988
30. The hybrid cytomegalovirus enhancer/chicken beta-actin promoter along with woodchuck hepatitis virus posttranscriptional regulatory element enhances the protective efficacy of DNA vaccines. Garg S, Oran AE, Hon H, Jacob J, J Immunol 2004 173 550 558 15210816 (Pubitemid 38797383)
31. Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis. Rissanen TT, Korpisalo P, Markkanen JE, Liimatainen T, Orden MR, Kholova I, de Goede A, Heikura T, Grohn OH, Yla-Herttuala S, Circulation 2005 112 3937 3946 10.1161/CIRCULATIONAHA.105.543124 16344386 (Pubitemid 43739492)
32. AAV-mediated VEGF gene transfer into skeletal muscle stimulates angiogenesis and improves blood flow in a rat hindlimb ischemia model. Shimpo M, Ikeda U, Maeda Y, Takahashi M, Miyashita H, Mizukami H, Urabe M, Kume A, Takizawa T, Shibuya M, et al. Cardiovasc Res 2002 53 993 1001 10.1016/S0008-6363(01)00546-6 11922909 (Pubitemid 34261037)
33. Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle. Karvinen H, Pasanen E, Rissanen TT, Korpisalo P, Vahakangas E, Jazwa A, Giacca M, Yla-Herttuala S, Gene Ther 2011 18 1166 1172 10.1038/gt.2011.66 21562595
34. Armulik A, Abramsson A, Betsholtz C, Endothelial/pericyte interactions. Circ Res 2005 97 512 523
35. Enhanced smooth muscle cell coverage of microvessels exposed to increased hemodynamic stresses in vivo. Van Gieson EJ, Murfee WL, Skalak TC, Price RJ, Circ Res 2003 92 929 936 10.1161/01.RES.0000068377.01063.79 12663481 (Pubitemid 36542535)
36. VEGF over-expression in skeletal muscle induces angiogenesis by intussusception rather than sprouting. Gianni-Barrera R, Trani M, Fontanellaz C, Heberer M, Djonov V, Hlushchuk R, Banfi A, Angiogenesis 2013 16 123 136 10.1007/s10456-012-9304-y 22961440
37. Nerve growth factor promotes angiogenesis and arteriogenesis in ischemic hindlimbs. Emanueli C, Salis MB, Pinna A, Graiani G, Manni L, Madeddu P, Circulation 2002 106 2257 2262 10.1161/01.CIR.0000033971.56802.C5 12390957 (Pubitemid 35222222)
38. Transplantation of low dose CD34 + KDR + cells promotes vascular and muscular regeneration in ischemic limbs. Madeddu P, Emanueli C, Pelosi E, Salis MB, Cerio AM, Bonanno G, Patti M, Stassi G, Condorelli G, Peschle C, FASEB J 2004 18 1737 1739 15345695 (Pubitemid 39561668)
39. Adenovirus-mediated gene transfer of human vascular endothelial growth factor-d induces transient angiogenic effects in mouse hind limb muscle. Kholova I, Koota S, Kaskenpaa N, Leppanen P, Narvainen J, Kavec M, Rissanen TT, Hazes T, Korpisalo P, Grohn O, et al. Hum Gene Ther 2007 18 232 244 10.1089/hum.2006.100 17362136 (Pubitemid 46626462)
40. Fibroblast growth factors and their receptors. Galzie Z, Kinsella AR, Smith JA, Biochem Cell Biol 1997 75 669 685 10.1139/o97-091 9599656 (Pubitemid 127733222)
41. Involvement of the fibroblast growth factor system in adaptive and chemokine-induced arteriogenesis. Deindl E, Hoefer IE, Fernandez B, Barancik M, Heil M, Strniskova M, Schaper W, Circ Res 2003 92 561 568 10.1161/01.RES. 0000061181.80065.7D 12600883 (Pubitemid 36368670)